P-048 - EVALUATION OF THE SINGLE DOSE PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY OF GS-3583, A FLT3 AGONIST FC FUSION PROTEIN, IN A PHASE 1 STUDY IN HEALTHY VOLUNTEERS.
A. Dauki1, N. Rajakumaraswamy1, T. Trowe1, I. Singh1, A. Vashishtha1, W. Weng1, M. Kuhne1, A. Qin1, C. Schwabe2, A. Othman1; 1Gilead Sciences, Inc., Foster City, CA, USA, 2New Zealand Clinical Research, Auckland, New Zealand.
.png)